MCM2 and astrocytoma (excluding glioblastoma): MCM2, 3 and 6 that were overexpressed in our material (Table 5) are associated to poor prognosis in lung cancer[25], astrocytoma[26] and craniopharyngeal carcinoma[27] respectively.